PARIS — In a move to bolster its skin health activity, Nestlé said it is acquiring the rights to commercialize the aesthetic dermatology products Restylane, Perlane, Emervel, Dysport and Sculptra in the U.S. and Canada from Valeant Pharmaceuticals International for $1.4 billion in cash.
Nestlé said the U.S. and Canada together represent more than 50 percent of the global medical aesthetics market.
Hermès is launching a Laundromat pop-up shop in NYC - dubbed Hermèsmatic - where customers can bring their old scarves to be dip-dyed by an expert. Get all the details on WWD.com. #wwdnews (📷: @donstahl)